Xiao K, Chen Z, He S, Long Q, Chen Y
Immunol Res. 2025; 73(1):48.
PMID: 39920470
DOI: 10.1007/s12026-025-09596-8.
Zheng S, Qi W, Xue T, Zao X, Xie J, Zhang P
Heliyon. 2024; 10(20):e39176.
PMID: 39640799
PMC: 11620126.
DOI: 10.1016/j.heliyon.2024.e39176.
Jarmakiewicz-Czaja S, Sokal-Dembowska A, Ferenc K, Filip R
Cells. 2024; 13(22).
PMID: 39594627
PMC: 11593555.
DOI: 10.3390/cells13221879.
Cui H, Yang H, Qi X, Zhao Y, Huang T, Miao L
Vet Sci. 2024; 11(11).
PMID: 39591319
PMC: 11599047.
DOI: 10.3390/vetsci11110545.
Chen S, Guo B, Feng A, Wang X, Zhang S, Miao C
Mol Biomed. 2024; 5(1):46.
PMID: 39388072
PMC: 11467144.
DOI: 10.1186/s43556-024-00211-0.
Obtusifolin inhibits podocyte apoptosis by inactivating NF-κB signaling in acute kidney injury.
Xiang H, Wu Y, Zhang Y, Hong Y, Xu Y
Cytotechnology. 2024; 76(5):559-569.
PMID: 39188647
PMC: 11344750.
DOI: 10.1007/s10616-024-00638-x.
Anti-TNFα in inflammatory bowel disease: from originators to biosimilars.
Zeng Z, Lin H, Jiang M, Yuan J, Li X, Jia Y
Front Pharmacol. 2024; 15:1424606.
PMID: 39114362
PMC: 11303209.
DOI: 10.3389/fphar.2024.1424606.
inhibits the TNF-α-induced increase in intestinal epithelial tight junction permeability via a TLR-2 and PI3K-dependent inhibition of NF-κB activation.
Haque M, Kaminsky L, Abdulqadir R, Engers J, Kovtunov E, Rawat M
Front Immunol. 2024; 15:1348010.
PMID: 39081324
PMC: 11286488.
DOI: 10.3389/fimmu.2024.1348010.
NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies.
Rezaee A, Rahmanian P, Nemati A, Sohrabifard F, Karimi F, Elahinia A
Heliyon. 2024; 10(9):e29871.
PMID: 38707342
PMC: 11066643.
DOI: 10.1016/j.heliyon.2024.e29871.
[Research advances on B-cell activating factor and its targeted agents in inflammatory bowel disease].
Li L, Liu H, Wang L
Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(3):315-320.
PMID: 38557386
PMC: 10986372.
DOI: 10.7499/j.issn.1008-8830.2309126.
Natural compounds target programmed cell death (PCD) signaling mechanism to treat ulcerative colitis: a review.
Chen B, Dong X, Zhang J, Sun X, Zhou L, Zhao K
Front Pharmacol. 2024; 15:1333657.
PMID: 38405669
PMC: 10885814.
DOI: 10.3389/fphar.2024.1333657.
Poly-(ADP-ribose) polymerases inhibition by olaparib attenuates activities of the NLRP3 inflammasome and of NF-κB in THP-1 monocytes.
Mustafa K, Han Y, He D, Wang Y, Niu N, Jose P
PLoS One. 2024; 19(2):e0295837.
PMID: 38335214
PMC: 10857571.
DOI: 10.1371/journal.pone.0295837.
Silencing HE4 alleviates the renal fibrosis in lupus nephritis mice by regulating the C3/MMPs/prss axis.
Li Y, Zhong X, Yang F
Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(7):4823-4831.
PMID: 38157023
PMC: 11166803.
DOI: 10.1007/s00210-023-02883-x.
Understanding very early onset inflammatory bowel disease (VEOIBD) in relation to inborn errors of immunity.
Hall C, de Zoeten E
Immunol Rev. 2023; 322(1):329-338.
PMID: 38115672
PMC: 11044353.
DOI: 10.1111/imr.13302.
CRISPR-Cas-Based Engineering of Probiotics.
Liu L, Helal S, Peng N
Biodes Res. 2023; 5:0017.
PMID: 37849462
PMC: 10541000.
DOI: 10.34133/bdr.0017.
Research progress of NF-κB signaling pathway and thrombosis.
Wang Z, Fang C, Yao M, Wu D, Chen M, Guo T
Front Immunol. 2023; 14:1257988.
PMID: 37841272
PMC: 10570553.
DOI: 10.3389/fimmu.2023.1257988.
, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases.
Gravina A, Pellegrino R, Auletta S, Palladino G, Brandimarte G, DOnofrio R
World J Gastroenterol. 2023; 29(20):3048-3065.
PMID: 37346156
PMC: 10280799.
DOI: 10.3748/wjg.v29.i20.3048.
An integrated transcriptome and microbial community analysis reveals potential mechanisms for increased immune responses when replacing silybum marianum meal with soybean meal in growing lambs.
Zhang T, Ren Y, Yang C, Gebeyew K, Gao M, He Z
Front Microbiol. 2023; 14:1093129.
PMID: 36937266
PMC: 10018209.
DOI: 10.3389/fmicb.2023.1093129.